Prudential Hong Kong Limited has announced an expansion of its cross-border Medical Expenses Direct Billing Services for cancer treatment within the Greater Bay Area. This initiative is a partnership with Foshan Fosun Chancheng Hospital and the Hong Kong Integrated Oncology Centre (HKIOC), intended to provide healthcare services for cancer patients across borders.
The collaboration introduces the “Cancer Patients Shared Care” model. Under this model, eligible Prudential customers will have access to multidisciplinary consultations and treatment plans from both Foshan Fosun Chancheng Hospital and HKIOC. A case management team will offer support throughout the treatment process, facilitating referrals between the two oncology centres. This process aims to streamline patient care.
This partnership follows Prudential’s earlier collaboration with Foshan Fosun Chancheng Hospital, announced in May. The current alliance combines the resources of the three entities to address health solutions.
Cancer remains a significant health issue in the region. Data indicates that in Hong Kong, one person is diagnosed with cancer every 15 minutes, while on the Chinese mainland, this figure is nine people every minute. The company noted in a news release that Prudential’s 2024 Individual Life Claims Report identifies cancer as a leading cause of both critical illness and death claims.
A feature of this partnership is the Medical Expenses Direct Billing Service. Eligible Prudential customers can obtain advance estimates for cancer treatment expenses from either hospital. Following pre-approval from Prudential, the company will directly settle the approved medical expenses with the institutions after treatment.
“Prudential is proud to collaborate with Foshan Fosun Chancheng Hospital and the Hong Kong Integrated Oncology Centre to launch the Medical Expenses Direct Billing Service for cross-border cancer treatment. By leveraging the ‘Cancer Patients Shared Care’ model and the combined strengths of all three parties, this partnership enables customers to access high-quality and seamless medical services across both Hong Kong and Chinese mainland,” said Lawrence Lam, CEO at Prudential Hong Kong Limited.
Hu Hang, CEO of Shanghai Fosun Health Technology and director of Foshan Fosun Chancheng Hospital, also commented on the collaboration’s function in connecting medical care for Hong Kong patients on the Chinese mainland. “This not only redefines the cross-border healthcare experience but also sets a new benchmark for medical integration in the Greater Bay Area through a full-cycle health management ecosystem driven by three-party synergy,” he said.
Tong Ka Kei, CEO of HKIOC, stated the aim is to allow patients and their families to focus on treatment and recovery. “We hope this collaboration will foster medical communication between Hong Kong and Foshan and serve as a model for advancing healthcare integration in the Greater Bay Area, benefiting more cancer patients,” he said.
What are your thoughts on this collaboration? Share your insights in the comments below.
